Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

(The Hill) — Former U.S. Surgeon General Jerome Adams on Sunday pushed back against the Department of Health and Human Services (HHS) recently winding down its mRNA vaccine development activities via ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology. He's seen here at a Sept. 4, 2025, hearing before the Senate Finance ...

Health Secretary Robert F. Kennedy Jr.’s decision to cancel $500 million in grants and contracts for mRNA vaccine development jeopardizes the health and safety of Americans — both now and for years to ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Deborah Fuller, University of Washington (THE CONVERSATION) At a Sept. 4, 2025, ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

A few-week-old Heidschnucken lamb moves through the heath with the flock. Scientists in Germany have successfully tested a new vaccine against foot-and-mouth disease (FMD) that could make handling the ...

Joel Mokyr, Philippe Aghion and Peter Howitt won the prize for showing how “society must keep an eye on the factors that ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...